Poulton Jeffrey V.
EVP, Chief Financial Officer
Poulton Jeffrey V. has filed 6 SEC Form 4 filings (58 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Mar 6, 2026.
On the most recent filing, Poulton Jeffrey V. is listed as EVP, Chief Financial Officer at ALNYLAM PHARMACEUTICALS, INC. Inside the rolling window, Poulton Jeffrey V. reported no open-market purchases and 5 open-market sales totaling $5.0M in ALNY. The largest disclosed transaction in the window is a sale of 3,821 ALNY shares on Oct 2, 2025, worth $1.7M.
Companies traded
Other insiders at ALNY
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Poulton Jeffrey V. made?
Poulton Jeffrey V. has filed 6 SEC Form 4 filings (58 transaction rows) across 1 company since 2025.
Which companies does Poulton Jeffrey V. trade?
Poulton Jeffrey V. has filed SEC Form 4 disclosures for 1 company, including ALNY.
When was Poulton Jeffrey V.'s most recent SEC Form 4 filing?
Poulton Jeffrey V.'s most recent SEC Form 4 filing on Tracefour is dated Mar 6, 2026.
What is Poulton Jeffrey V.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Poulton Jeffrey V. is listed as EVP, Chief Financial Officer.
What is Poulton Jeffrey V.'s total buy and sell value in the current window?
Inside the rolling retention window, Poulton Jeffrey V. bought $0 and sold $5.0M based on SEC Form 4 filings.
What was Poulton Jeffrey V.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,821 ALNY shares on 2025-10-02, worth $1.7M, per SEC Form 4 filings.